0001209191-23-036733.txt : 20230613
0001209191-23-036733.hdr.sgml : 20230613
20230613163834
ACCESSION NUMBER: 0001209191-23-036733
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230609
FILED AS OF DATE: 20230613
DATE AS OF CHANGE: 20230613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Randolph Sophia
CENTRAL INDEX KEY: 0001817127
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39386
FILM NUMBER: 231011713
MAIL ADDRESS:
STREET 1: C/O ALX ONCOLOGY HOLDINGS INC.
STREET 2: 866 MALCOLM ROAD, SUITE 100
CITY: BURLINGAME
STATE: CA
ZIP: 94010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALX ONCOLOGY HOLDINGS INC
CENTRAL INDEX KEY: 0001810182
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 850642577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 323 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-466-7125
MAIL ADDRESS:
STREET 1: 323 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-09
0
0001810182
ALX ONCOLOGY HOLDINGS INC
ALXO
0001817127
Randolph Sophia
C/O ALX ONCOLOGY HOLDINGS INC.
323 ALLERTON AVENUE
SOUTH SAN FRANCISO
CA
94080
1
1
0
0
Chief Medical Officer
0
Common Stock
2023-06-09
4
M
0
4027
1.91
A
274280
D
Common Stock
2023-06-09
4
M
0
2546
4.08
A
276826
D
Common Stock
2023-06-09
4
M
0
6256
4.81
A
283082
D
Employee Stock Option (right to buy)
1.91
2023-06-09
4
M
0
4027
0.00
D
2029-09-12
Common Stock
4027
0
D
Employee Stock Option (right to buy)
4.08
2023-06-09
4
M
0
2546
0.00
D
2030-03-09
Common Stock
2546
92629
D
Employee Stock Option (right to buy)
4.81
2023-06-09
4
M
0
6256
0.00
D
2030-04-27
Common Stock
6256
19084
D
The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on June 16, 2019.
The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on April 9, 2020.
Shares subject to the option vest in 48 equal monthly installments beginning on May 27, 2020.
/s/ Peter Garcia, by power of attorney
2023-06-13